Earnings FeedTerminal

⌘K

Home/Filings/6-K/0000818686-11-000053

6-K//Foreign company update

TEVA PHARMACEUTICAL INDUSTRIES LTD 6-K

Accession 0000818686-11-000053

$TEVACIK 0000818686operating

View on SEC.gov Company Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 8:58 AM ET

Size

128.4 KB

Accession

0000818686-11-000053

Documents

3 files

6-K
curtisren190511.htmPrimary
TEVA AND ONCOGENEX TO PRESENT DATA ON CUSTIRSEN IN PROSTATE CANCER AT THE 2011 ASCO ANNUAL MEETING
6-K
curtisren190511.pdfPrimary
TEVA AND ONCOGENEX TO PRESENT DATA ON CUSTIRSEN IN PROSTATE CANCER AT THE 2011 ASCO ANNUAL MEETING
GRAPHIC
image001.jpg
GRAPHIC

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeoperating

IncorporatedIsrael

Related Parties

1

filerCIK 0000818686

Filing Metadata

Form type: 6-K
Filed: May 18, 8:00 PM ET
Accepted: May 19, 8:58 AM ET
Size: 128.4 KB

View on SEC.gov